Zentalis Pharmaceuticals, Inc. (ZNTL)
2.885
-0.08
(-2.53%)
USD |
NASDAQ |
Jan 20, 15:29
Zentalis Pharmaceuticals Total Assets (Quarterly): 327.25M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 42.71B |
| STAAR Surgical Co. | 456.36M |
| Glaukos Corp. | 999.38M |
| Perspective Therapeutics, Inc. | 294.82M |
| Electromed, Inc. | 53.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 74.38M |
| Shareholders Equity (Quarterly) | 252.87M |
| Debt to Equity Ratio | 0.16 |
| Current Ratio | 7.757 |
| Net Debt Paydown Yield | 0.65% |